Bionomics Limited
Bionomics Limited (BNOEF) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
bnoef · pe ratio · data through Jun 30, 2024
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for Bionomics Limited (BNOEF) measures how much investors pay for each dollar of the company's trailing earnings. BNOEF's current PE ratio of N/A is calculated by dividing its stock price of $0.01 by its TTM earnings per share of -$5.09.
Source: FMP · /ratios-ttm · /analyst-estimates · 2024-06-30
PE Ratio History
2005 – 2024 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
PE Ratio vs Peers
Biotechnology · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
Bionomics LimitedYou BNOEF | $9M | N/A | — | -$5.09 |
 Eiger BioPharmaceuticals, Inc. EIGRQ | $13M | N/A | — | -$50.78 |
 The Flowr Corporation FLWPF | $0M | N/A | — | -$0.23 |
 Forward Pharma A/S FWPAY | $7M | N/A | — | -$77.41 |
 HealthBeacon plc HBCNF | $8M | N/A | — | -$0.78 |
 Immune Therapeutics, Inc. IMUN | $8M | N/A | — | -$0.16 |
 Living Cell Technologies Limited LVCLY | $11M | N/A | — | -$0.01 |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2024-06-30Latest FY2024 | — | $-1898.63 | — | |
2023-06-30 FY2023 | — | $-2.60 | — | |
2022-06-30 FY2022 | — | $-2.48 | — | |
2021-06-30 FY2021 | — | $-2.01 | — | |
2020-06-30 FY2020 | — | $-1.62 | — | |
2019-06-30 FY2019 | — | $-2.34 | — | |
2018-06-30 FY2018 | — | $-6.88 | — | |
2017-06-30 FY2017 | — | $-1.94 | — | |
2016-06-30 FY2016 | — | $-4.87 | — | |
2015-06-30 FY2015 | — | $-5.60 | — |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for Bionomics Limited (BNOEF) measures how much investors pay for each dollar of the company's trailing earnings. BNOEF's current PE ratio of N/A is calculated by dividing its stock price of $0.01 by its TTM earnings per share of -$5.09.
Frequently asked questions
BNOEF pe ratio · 6 questionsBNOEF's current PE ratio is N/A as of 2026-06-09, based on a stock price of $0.01 and TTM EPS of -$5.09. Data sourced from Financial Modeling Prep via BNOEF's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Bionomics Limited SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-09